Eye health Drugs: Medicare Part D Spending

• 98medicines with Part D spending (calendar year 2024)

Each number has its full source under its own list below.

1. 1RestasisCyclosporine · $10.20 per unit$1.3 billion
2. 2LumiganBimatoprost · $96.72 per unit$647.2 million
3. 3Cyclosporine*Cyclosporine · $4.33 per unit$305.2 million
4. 4CombiganBrimonidine Tartrate/Timolol · $38.75 per unit$162.3 million
5. 5Prednisolone AcetatePrednisolone Acetate · $5.46 per unit$155 million
6. 6Varenicline TartrateVarenicline Tartrate · $3.50 per unit$132.5 million
7. 7Brimonidine Tartrate*Brimonidine Tartrate · $3.90 per unit$97.6 million
8. 8Alphagan PBrimonidine Tartrate · $37.44 per unit$92.7 million
9. 9Azelastine HCl*Azelastine HCl · $1.07 per unit$86.1 million
10. 10Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol · $16.98 per unit$84.1 million
11. 11CequaCyclosporine · $9.34 per unit$76.6 million
12. 12TravoprostTravoprost · $30.77 per unit$75.1 million
13. 13TyrvayaVarenicline Tartrate · $76.54 per unit$71.7 million
14. 14Restasis MultidoseCyclosporine · $111.94 per unit$64.2 million
15. 15Dorzolamide-TimololDorzolamide HCl/Timolol Maleat · $1.43 per unit$55.7 million

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

• Cataract operations

• Pediatric
• Diabetes
• Infectious diseases